pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 8·1 min read
save

ACA insurers seek median 14% premium hike for 2027 as enrollment falls

Jul 8, 2026·read at STAT ↗RegulatoryNegative

Insurers filing with state regulators for 2027 ACA plans are asking for a median premium increase of 14%, according to an analysis of filings in 16 states and the District of Columbia.

This would be the second-largest rise since 2018 and follows a year of double-digit hikes, driven by higher medical costs and recent policy shifts.

Consumers could feel a triple whammy because they already faced higher premiums in 2026 and the enhanced tax credits introduced by the Biden administration expired at the end of last year.

The shift reflects the Trump administration's effort to reduce federal subsidies for ACA coverage, contrasting with earlier moves to expand them and boost enrollment beyond 20 million.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Affordable Care Act insurers want more premium increases as enrollment sags”

read at STAT ↗
1,071 words · retrieved Jul 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING4
topics
Obesity

related stories

  • Jul 24STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pillSTAT
  • Jul 23Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clearFierce Biotech
  • Jul 21Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesityBioSpace
  • Jul 21STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and moreSTAT
  • Jul 21STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’STAT